Medpace

Forecast & Rating13 analysts currently cover Medpace, with about 15.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $570.67, about 5.1% downside from the current price of $601.38. Price targets range from $370.00 to $692.00 — a wide spread, showing clear disagreement over just how much Medpace can rise. Historically, about 94.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Medpace's outlook. Data as of Jul 24, 2026; for reference only and not investment advice.